13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001012975-25-000761
Total Value
$238.0M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | 922042775 | 2,578,184 | $184.0M | 77.31% |
| 2 | ISHARES TR | 46429B598 | 369,600 | $19.2M | 8.08% |
| 3 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $11.9M | 4.99% |
| 4 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $7.7M | 3.23% |
| 5 | ALECTOR INC | ALEC | 1,307,858 | $3.9M | 1.63% |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $3.7M | 1.55% |
| 7 | SPDR S&P 500 ETF TR | SPY | 4,104 | $2.7M | 1.15% |
| 8 | RAPT THERAPEUTICS INC | 75382E208 | 82,234 | $2.1M | 0.89% |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $1.6M | 0.69% |
| 10 | SURROZEN INC | SRZNW | 87,696 | $1.1M | 0.47% |
| 11 | SURROZEN INC | SRZNW | 170,833 | $3,417 | 0.00% |